AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support
Executive Summary
Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.
You may also be interested in...
How Can Korea Grab Window Of Opportunity In AI Drug Development?
Participants at a recent policy forum in Seoul stressed the need to secure appropriate technology and expertise, unify government support and draw up a joint cooperation plan between industry and government as key factors in advancing AI-guided new drug development in South Korea.
Korea 2018 Review: Hopes And Worries Coexist In Pharma Sector
As the year end approaches, Scrip wraps up what major events made headlines in the South Korean pharma/biotech sector in 2018.
What's Keeping Korea From Becoming A Digital Healthcare Power?
While digital healthcare start-ups are increasingly being established in South Korea, strict regulations and a limited market environment are keeping them from adopting innovative ideas and technologies to rapidly catch up with global competitors. A recent report on digital healthcare suggests what issues need to be resolved to improve the situation.